ViewRay Announces Results of the First Prospective Clinical Trial on MR-guided Radiation Treatment for Prostate Cancer Without Implanted Markers
Study Shows Low Incidence of Early Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Eliminating Potential Complications and Costs Associated with Implanted Markers
CLEVELAND, Aug. 19, 2019 -- (Healthcare Sales & Marketing Network) -- Vie... Devices, Oncology ViewRay, Stereotactic, MR-guided, radiotherapy, prostate cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Marketing | Pharmaceuticals | Prostate Cancer | Radiation Therapy | Study | Toxicology